A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease.
The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and US-based pharmaceutical-grade medical cannabis producer AXIM Biotechnologies.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.